Drug toxicity predicted by differences between preclinical models and humans
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 18-Nov-2025 02:11 ET (18-Nov-2025 07:11 GMT/UTC)
The published paper reports on the results of more than 5 years of collaboration and introduces a new instrument that the scientific community can use to accurately integrate ex-vivo dissection and in-vivo tractography data. These two complementary techniques had never been integrated so far into the study of human white matter connections, and this confirms a new research trend, where multidisciplinary competencies converge, in this case clinical neuroscience and artificial intelligence. The study opens new frontiers for Neurosurgery in the treatment of brain tumors and the approach to degenerative neurological disorders, and in Neuro-rehabilitation to harness the potential of brain plasticity. The new instrument, called BraDiPho (Brain Dissection Photogrammetry), is the result of the joint effort of the University of Trento, the Provincial Healthcare Services of Trento (Apss) and Fondazione Bruno Kessler, in collaboration with the University of Bordeaux (France) and the University of Sherbrooke (Canada).
A new study has revealed that artificial intelligence can now generate images of real people that are virtually impossible to tell apart from genuine photographs. Using AI models an international partnership of researchers created highly realistic images of both fictional and famous faces, including celebrities. They found that participants were unable to reliably distinguish them from authentic photos—even when they were familiar with the person’s appearance.
A rigorous systematic review of the present state of knowledge on the use of acetaminophen during pregnancy and the risk of specific neurodevelopmental disorders (NDDs), such as autism and ADHD, offers reassurance that acetaminophen does not increase the risk of NDDs. The study in the Journal of the American Academy of Child & Adolescent Psychiatry (JAACAP), published by Elsevier, points to methodological inadequacies in previous reviews and studies. It offers reassurance for pregnant women, public health agencies, and healthcare providers in alignment with recommendations from the Centers for Disease Control and Prevention (CDC), American College of Obstetricians and Gynecologists (ACOG), and The Society of Obstetricians and Gynecologists of Canada (SOGC).